HORG trial

Date 30 September 2019
Event ESMO 2019 Congress
Session Adjuvant treatment duration for high-risk stage II colon cancer
Topics Oesophageal Cancer
Gastric Cancer
Anal Cancer
Hepatobiliary Cancers
Pancreatic Cancer
Colon and Rectal Cancer
Gastrointestinal Cancers
Presenter Ioannis Souglakos
Authors I. Souglakos
  • Medical Oncology Dept, University Hospital of Heraklion (PAGNI), 715 00 - Heraklion/GR